$ Value
$460K
Shares
28,768
Price
$16
Filed
Feb 27
Insider
Name
Hawryluk P. Kent
Title
President & CEO
CIK
0001673991
Roles
Transaction Details
Transaction Date
2026-02-26
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
728,274
Footnotes
Shares held by the P. Kent Hawryluk Revocable Trust dated January 25, 2011, of which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose. | 25% of the shares underlying this option vested and became exercisable on September 12, 2025, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Filing Info
Hawryluk P. Kent's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-26 | MBX | M | $460K |
| 2026-02-26 | MBX | M | $0 |
| 2026-02-02 | MBX | A | $0 |
| 2026-02-02 | MBX | A | $0 |
| 2025-10-24 | MBX | M | $594K |
| 2025-10-24 | MBX | M | $0 |
| 2025-10-20 | MBX | ▲ | $273K ★ |
Other Insiders at MBX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Hoerter Steven L. | — | — | 2025-11-22 |
|
Hawryluk P. Kent
President & CEO
|
— | — | 2026-02-26 |
|
Bartram Richard
Chief Financial Officer
|
— | — | 2026-02-02 |
|
Azoulay Salomon
Chief Medical Officer
|
— | — | 2026-02-02 |